Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

ABSTRACT:

Background

Disparities in public assistance or the urbanization level of a residential region can affect cancer treatment outcomes. This study aimed to investigate whether these factors affect the overall survival (OS) of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) using Tokushukai REAL World Data.

Methods

We analyzed the clinical data of consecutive patients with NSCLC receiving EGFR-tyrosine kinase inhibitors between April 2010 and March 2020 at 46 Tokushukai Medical Group hospitals in Japan. The patient's insurance coverage status was extracted from electronic medical records, and the urbanization level of residential regions was classified as megalopolis or other according to the secondary medical region. Uni

SUBMITTER: Uryu K 

PROVIDER: S-EPMC11882504 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature